{"id":125338,"date":"2026-06-22T12:11:36","date_gmt":"2026-06-22T06:41:36","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=125338"},"modified":"2026-06-22T12:11:39","modified_gmt":"2026-06-22T06:41:39","slug":"cipla-share-price-today-june-22-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/","title":{"rendered":"Cipla Share Price Today, June 22, 2026: Stock Surges 3.62% to Rs 1,400.80"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>CIPLA CMP Rs 1,400.80, up 3.62%. Prev close Rs 1,351.80. High Rs 1,403. Low Rs 1,370.60. Pharma momentum drives sharp gains today.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\">Cipla<\/a> share price jumped 3.62% to Rs 1,400.80 on June 22, 2026, making it one of the top gainers in the pharmaceutical sector today. The Mumbai-based drug maker is among the most searched share prices on Google with over 500 active queries as the stock approaches its 52-week high range. The session high was Rs 1,403 and the low was Rs 1,370.60, with the previous close at Rs 1,351.80.<\/p>\n<p>Cipla is one of India&#8217;s largest pharmaceutical companies, with a diversified portfolio spanning branded generics in India, regulated markets in the US and Europe, and emerging market businesses across Africa and South Asia. The company has been delivering consistent performance, with its US generics pipeline and India prescription business driving earnings growth.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=cipla-share-price-today\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#Cipla_Share_Price_Live_Data_for_June_22_2026\" title=\"Cipla Share Price: Live Data for June 22, 2026\">Cipla Share Price: Live Data for June 22, 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#Why_Cipla_Share_Price_Is_Surging_Today\" title=\"Why Cipla Share Price Is Surging Today\">Why Cipla Share Price Is Surging Today<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#1_Pharma_Sector_Re-Rating_and_Positive_Momentum\" title=\"1. Pharma Sector Re-Rating and Positive Momentum\">1. Pharma Sector Re-Rating and Positive Momentum<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#2_US_Generics_Pipeline_Progress\" title=\"2. US Generics Pipeline Progress\">2. US Generics Pipeline Progress<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#3_India_Prescription_Business_Strong_Growth\" title=\"3. India Prescription Business Strong Growth\">3. India Prescription Business Strong Growth<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#What_Investors_Should_Watch_for_Cipla_Share_Price\" title=\"What Investors Should Watch for Cipla Share Price\">What Investors Should Watch for Cipla Share Price<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#What_is_Cipla_share_price_today\" title=\"What is Cipla share price today?\">What is Cipla share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#Why_is_Cipla_share_price_rising_today\" title=\"Why is Cipla share price rising today?\">Why is Cipla share price rising today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#What_is_Ciplas_main_business\" title=\"What is Cipla&#8217;s main business?\">What is Cipla&#8217;s main business?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#What_is_Ciplas_US_inhaler_pipeline\" title=\"What is Cipla&#8217;s US inhaler pipeline?\">What is Cipla&#8217;s US inhaler pipeline?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#Is_Cipla_a_good_stock_to_buy\" title=\"Is Cipla a good stock to buy?\">Is Cipla a good stock to buy?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#What_is_CIPLAs_USFDA_status\" title=\"What is CIPLA&#8217;s USFDA status?\">What is CIPLA&#8217;s USFDA status?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#What_are_the_risks_for_Cipla_investors\" title=\"What are the risks for Cipla investors?\">What are the risks for Cipla investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/cipla-share-price-today-june-22-2026\/#Where_can_I_track_Cipla_share_price_live\" title=\"Where can I track Cipla share price live?\">Where can I track Cipla share price live?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Cipla_Share_Price_Live_Data_for_June_22_2026\"><\/span><strong>Cipla Share Price: Live Data for June 22, 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>NSE Symbol<\/td>\n<td>CIPLA<\/td>\n<\/tr>\n<tr>\n<td>CMP<\/td>\n<td>Rs 1,400.80<\/td>\n<\/tr>\n<tr>\n<td>Change<\/td>\n<td>+3.62%<\/td>\n<\/tr>\n<tr>\n<td>Previous Close<\/td>\n<td>Rs 1,351.80<\/td>\n<\/tr>\n<tr>\n<td>Day&#8217;s High<\/td>\n<td>Rs 1,403.00<\/td>\n<\/tr>\n<tr>\n<td>Day&#8217;s Low<\/td>\n<td>Rs 1,370.60<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceuticals<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background: #E8EAFF; border-radius: 14px; padding: 28px 32px 24px 32px; margin: 24px 0; font-family: -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,sans-serif; cursor: pointer; max-width: 100%; box-sizing: border-box;\">\n<p style=\"font-size: 20px; font-weight: bold; color: #0a0a23; margin: 0 0 12px 0; line-height: 1.3;\">Top Pharma Stocks on Analysts&#8217; Research List on Univest<\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">When <strong style=\"color: #0a0a23;\">Univest analysts<\/strong> identify high-conviction stock opportunities, <em>investors pay attention.<\/em><\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">Our research team has shortlisted the <strong style=\"color: #0a0a23;\">Top Stocks to Buy<\/strong> based on current market momentum, sector trends &amp; growth potential for 2026.<\/p>\n<ul style=\"margin: 0 0 16px 20px; padding: 0; color: #3a3a5c; font-size: 15px; line-height: 1.8;\">\n<li>Discover stocks investors are actively accumulating<\/li>\n<li>High-conviction opportunities backed by research<\/li>\n<li>Designed for the next phase of market growth<\/li>\n<\/ul>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 20px 0;\">Unlock the latest <a style=\"color: #3b7fff; font-weight: bold; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\">Top Stock Picks<\/a> on Univest<\/p>\n<p><a style=\"display: inline-block; background: #3B7FFF; color: #fff; font-size: 15px; font-weight: 600; padding: 13px 28px; border-radius: 50px; letter-spacing: 0.2px; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">See the Stocks \u2192<\/a><\/p>\n<\/div>\n<p>Cipla share price has been on a strong upward trajectory over the past year, supported by the company&#8217;s improving US generics business, strong India prescription market execution, and a clean regulatory track record with the USFDA. The company&#8217;s focus on differentiated and complex generics in the US market is helping it sustain pricing power in an otherwise competitive generics environment.<\/p>\n<p>The respiratory drugs segment, particularly the US inhaler products pipeline, is a key long-term value driver for Cipla. The company has been working on multiple complex respiratory formulations including generic versions of branded US inhalers, which, upon approval, could provide significant revenue uplifts given the large size of the US respiratory market.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Cipla_Share_Price_Is_Surging_Today\"><\/span><strong>Why Cipla Share Price Is Surging Today<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Three factors are driving Cipla share price 3.62% higher today. Investors can use the Univest Screener to track CIPLA&#8217;s live fundamentals and compare it with pharma sector peers including Sun Pharma, Dr Reddy&#8217;s, and Divi&#8217;s Labs.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Track Cipla and Pharma Sector Stocks on Univest Screener<\/strong><\/a><\/p>\n<h3><span class=\"ez-toc-section\" id=\"1_Pharma_Sector_Re-Rating_and_Positive_Momentum\"><\/span><strong>1. Pharma Sector Re-Rating and Positive Momentum<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Indian pharmaceutical sector is experiencing a broad re-rating as investors recognise the structural growth in domestic prescription volumes, improving US FDA inspection outcomes, and the global trend toward generic drug adoption. Cipla share price is benefiting from this sector-wide momentum, with institutions and retail investors both participating in the rally.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_US_Generics_Pipeline_Progress\"><\/span><strong>2. US Generics Pipeline Progress<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Cipla&#8217;s US generics business has been a key earnings growth driver, with multiple ANDA approvals and product launches in recent quarters. The company&#8217;s focus on limited competition generics and complex respiratory products provides better pricing sustainability than commodity generic drugs, supporting both revenue and margin expansion.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_India_Prescription_Business_Strong_Growth\"><\/span><strong>3. India Prescription Business Strong Growth<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Cipla&#8217;s India business, which spans branded generics across cardiovascular, respiratory, anti-infective, and oncology segments, has been consistently growing above industry averages. The company&#8217;s strong field force, doctor relationships, and brand equity in key therapeutic categories are driving market share gains in the domestic formulations market.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Investors_Should_Watch_for_Cipla_Share_Price\"><\/span><strong>What Investors Should Watch for Cipla Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The most important near-term triggers for Cipla share price are Q1 FY27 results in July and any USFDA announcements on complex respiratory product approvals. Investors should also monitor the company&#8217;s commentary on US price erosion trends in the generics segment.<\/p>\n<p>Long-term investors tracking Cipla share price should watch the progress of the US inhaler products pipeline and the company&#8217;s expanding biosimilars portfolio. A successful launch of a complex respiratory product in the US could be a significant re-rating catalyst for the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Cipla share price surged 3.62% to Rs 1,400.80 on June 22, 2026, driven by pharma sector momentum and positive investor outlook on the company&#8217;s US generics pipeline and India prescription growth. The stock is one of the top performing large-cap pharma names today. This article is for informational purposes only. Consult a SEBI-registered financial advisor before making investment decisions.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Cipla share price live and access pharmaceutical sector stock research.<\/em><\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Cipla_share_price_today\"><\/span><strong>What is Cipla share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Cipla share price is Rs 1,400.80 on June 22, 2026, up 3.62% from the previous close of Rs 1,351.80. The day high is Rs 1,403 and the day low is Rs 1,370.60. Cipla trades on NSE under the symbol CIPLA.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Cipla_share_price_rising_today\"><\/span><strong>Why is Cipla share price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Cipla share price is rising today due to broad pharma sector momentum, positive investor outlook on the company&#8217;s US generics pipeline, and strong India prescription business performance. The stock is also benefiting from sector-wide institutional buying in pharmaceutical companies.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Ciplas_main_business\"><\/span><strong>What is Cipla&#8217;s main business?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Cipla is a pharmaceutical company that manufactures and sells branded generic medicines in India, generic drugs in the US and other regulated markets, and formulations in emerging markets across Africa and South Asia. Its key segments include India prescription, North America generics, and international branded formulations.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Ciplas_US_inhaler_pipeline\"><\/span><strong>What is Cipla&#8217;s US inhaler pipeline?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Cipla has been developing complex generic inhalers for the US market that are bioequivalent to major branded respiratory drugs. These are difficult-to-formulate products with limited generic competition, which provides Cipla with better pricing and margin potential compared to standard generics upon USFDA approval.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Cipla_a_good_stock_to_buy\"><\/span><strong>Is Cipla a good stock to buy?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Cipla is one of India&#8217;s most respected pharmaceutical companies with a strong regulatory track record, diversified market presence, and a growing complex generics pipeline. Whether it suits your portfolio depends on your investment horizon and view on the pharma cycle. This is not investment advice. Consult a SEBI-registered advisor.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_CIPLAs_USFDA_status\"><\/span><strong>What is CIPLA&#8217;s USFDA status?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Cipla has a generally good track record with USFDA inspections across its manufacturing plants. Investors should verify the current status of any outstanding inspection observations or Warning Letters via the USFDA&#8217;s official website or the company&#8217;s latest investor communications.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_for_Cipla_investors\"><\/span><strong>What are the risks for Cipla investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks include US generics price erosion, USFDA regulatory actions at manufacturing facilities, competition in the India branded generics market, currency risk from dollar revenue, and clinical or approval delays for complex product filings including respiratory inhalers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Cipla_share_price_live\"><\/span><strong>Where can I track Cipla share price live?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Cipla share price can be tracked live on NSE at nseindia.com using the symbol CIPLA. The Univest app and Univest Screener provide live data and sector research on Cipla and other pharmaceutical stocks.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cipla share price surged 3.62% to Rs 1,400.80 today from Rs 1,351.80. Strong pharma sector momentum, US generics pipeline, and Q1 FY27 outlook are key catalysts for this jump.<\/p>\n","protected":false},"author":28,"featured_media":125419,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-125338","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1782110503:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["81"],"rank_math_title":["Cipla Share Price Today June 22, 2026 Live Data"],"rank_math_description":["Cipla share price surged 3.62% to Rs 1,400.80 today from Rs 1,351.80. Pharma sector momentum and Q1 FY27 results expectations drive strong buying interest."],"rank_math_focus_keyword":["Cipla Share Price"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["125419"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["19786"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Cipla-Share-Price-Today.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/125338","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=125338"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/125338\/revisions"}],"predecessor-version":[{"id":125420,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/125338\/revisions\/125420"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/125419"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=125338"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=125338"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=125338"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}